UNIGE document Professional Article - Meta-analysis
previous document  unige:24559  next document
add to browser collection

The kidney as a target organ in pharmaceutical research

Pomposiello, Silvia
Ghiggeri, Gianmarco
Published in Drug Discovery Today. 2011, vol. 16, no. 5-6, p. 244-59
Abstract Kidney diseases are a major source of morbidity and mortality in humans. In developed countries, mortality owing to chronic kidney disease (CKD) terminating in end-stage renal failure is comparable with that associated with cancer. A full understanding of the mechanisms implicated in the progression of CKD is needed to achieve its prevention and to delay the need for support strategies based on dialysis and transplantation. Renal fibrosis is the unifying feature of progressive renal alterations. In this review, we discuss the current status of possible mechanisms, tools and targets in CKD. Pathophysiological compound identification, biomarker discovery and accurate selection of clinical validation criteria appear to be three key elements needed to develop a successful innovative pharmaceutical approach to treating kidney diseases.
Keywords AnimalsBiological Markers/metabolismDisease ProgressionDrug Delivery SystemsFibrosisHumansKidney Diseases/drug therapy/physiopathologyKidney Failure, Chronic/drug therapy/physiopathology/prevention & control/therapyResearch/methods
PMID: 21129499
Full text
Article (Published version) (739 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Research group Analyse protéomique et Analyse génomique des maladies rénales (659)
(ISO format)
PRUNOTTO, Marco et al. The kidney as a target organ in pharmaceutical research. In: Drug Discovery Today, 2011, vol. 16, n° 5-6, p. 244-59. doi: 10.1016/j.drudis.2010.11.011 https://archive-ouverte.unige.ch/unige:24559

476 hits

0 download


Deposited on : 2012-12-14

Export document
Format :
Citation style :